STAGE III ENDOMETRIAL CARCINOMA

Clinical trials for STAGE III ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new STAGE III ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for STAGE III ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Cancer trial cuts radiation time from 5 weeks to just 1

Disease control Recruiting now

This study is testing whether a much shorter, one-week course of targeted pelvic radiation, given alongside standard chemotherapy drugs, is practical for patients to complete. It aims to see if this combined approach is manageable for people with stage III endometrial cancer who …

Matched conditions: STAGE III ENDOMETRIAL CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

STAGE III ENDOMETRIAL CARCINOMA

Get alerted when new STAGE III ENDOMETRIAL CARCINOMA trials appear

Cancer trial cuts radiation time from 5 weeks to just 1